Loading...

Home
ETF
VERU

VERU

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

VERU News

Veru Shares Surge 88% on Novo Nordisk Collaboration

Jun 05 2026NASDAQ.COM

Veru Partners with Novo Nordisk for Phase 2b PLATEAU Study

Jun 04 2026stocktwits

Veru Inc. Q2 Fiscal 2026 Earnings Call Insights

May 13 2026seekingalpha

Veru Reports Q2 Earnings Beat Expectations

May 13 2026seekingalpha

Veru Reports Q2 Financials and Clinical Trial Updates

May 13 2026Newsfilter

Veru Scheduled to Announce Q2 Earnings on May 13

May 12 2026seekingalpha

Veru Inc. to Host Q2 2026 Financial Results Conference Call

May 06 2026Newsfilter

Veru Initiates Phase 2b Clinical Trial for Enobosarm in Obesity Treatment

Mar 09 2026Newsfilter

Veru Inc. to Present at Oppenheimer Healthcare Conference

Feb 19 2026Newsfilter

Veru Inc. Q1 2026 Earnings Call Insights

Feb 11 2026seekingalpha

Veru Reports Q1 2025 Earnings with Significant Cash Increase

Feb 11 2026seekingalpha

Veru Initiates Phase 2b Clinical Trial for Obesity Drug Enobosarm

Feb 11 2026Newsfilter

Veru Scheduled to Announce Q1 Earnings on February 11

Feb 10 2026seekingalpha

Veru details 72-week Phase IIb PLATEAU study aimed at obesity plateau group in accordance with FDA recommendations.

Dec 17 2025SeekingAlpha

Key Stocks Reporting Earnings This Week: Micron, FuelCell, Carnival, and Others

Dec 15 2025Benzinga

Verusen Promotes Stuart Lynch to Director of Customer Success, Enhancing Supply Chain Optimization

Dec 05 2025Globenewswire